Position in ACB
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$404
-$174 QoQ
Shares Held
145
-18.1% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#52
of 149 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ACB Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Allworth Financial LP holds $7,771,550 across 48 Drug Manufacturers - Specialty & Generic names. ACB ranks #41 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
|
14,853 | $2,503,324 | |
| 2 | SUPN |
Supernus Pharmaceuticals, Inc.
|
50,669 | $2,356,615 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
1,167 | $632,315 | |
| 4 | ZTS |
Zoetis Inc.
|
6,658 | $478,443 | |
| 5 | VTRS |
Viatris Inc
|
18,367 | $291,667 | |
| 6 | TAK |
Takeda Pharmaceutical Co Ltd
|
13,516 | $216,661 | |
| 7 | ELAN |
Elanco Animal Health Inc
|
8,616 | $212,039 | |
| 8 | COLL |
Collegium Pharmaceutical, Inc
|
4,826 | $174,701 |
All Filings in ACB
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $404 | 145 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $578 | 177 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $700 | 166 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $5,113 | 858 | Shares | Sole | 2025-12-02 | |
| 2025-06-30 | $3,671 | 866 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $3,999 | 911 | Shares | Sole | 2025-04-30 | |
| 2024-12-31 | $3,680 | 866 | Shares | Sole | 2025-01-30 | |
| 2024-09-30 | $5,309 | 903 | Shares | Sole | 2024-10-23 | |
| 2024-06-30 | $4,130 | 894 | Shares | Sole | 2024-07-24 | |
| 2024-03-31 | $4,100 | 934 | Shares | Sole | 2024-04-25 | |
| 2023-12-31 | $476 | 1,002 | Shares | Sole | 2024-01-24 | |
| 2023-09-30 | $587 | 1,004 | Shares | Sole | 2023-10-31 | |
| 2023-06-30 | $541 | 1,012 | Shares | Sole | 2023-07-18 | |
| 2023-03-31 | $705 | 1,012 | Shares | Sole | 2023-04-18 | |
| 2022-12-31 | $936 | 1,015 | Shares | Sole | 2023-01-13 | |
| 2022-09-30 | $1,479 | 1,213 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $1,386 | 1,050 | Shares | Sole | 2022-07-13 | |
| 2022-03-31 | $4,372 | 1,093 | Shares | Sole | 2022-04-22 | |
| 2021-12-31 | $5,869 | 1,085 | Shares | Sole | 2022-01-21 | |
| 2021-09-30 | $7,508 | 1,085 | Shares | Sole | 2021-11-02 | |
| 2021-06-30 | $9,736 | 1,077 | Shares | Sole | 2021-08-02 | |
| 2021-03-31 | $10,026 | 1,077 | Shares | Sole | 2021-04-29 | |
| 2020-12-31 | $2,459 | 296 | Shares | Sole | 2021-01-26 | |
| 2020-09-30 | $1,311 | 282 | Shares | Sole | 2020-11-03 | |
| 2020-06-30 | $3,502 | 282 | Shares | Sole | 2020-07-24 | |
| 2020-03-31 | $7,029 | 7,759 | Shares | Sole | 2020-04-17 | |
| No filing history on record for this holder in this stock. | ||||||